2215-21-6

Applied Filters:

Keyword:'2215-21-6'

Showing 1-1 of 1 result for "2215-21-6" within Papers

Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.

Emily Li et al.

The Cochrane database of systematic reviews, 5, CD012208-CD012208 (2020-05-07)

Age-related macular degeneration (AMD) is one of the leading causes of permanent blindness worldwide. The current mainstay of treatment for neovascular AMD (nAMD) is intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents: aflibercept, ranibizumab, and off-label bevacizumab. Injections can

Page 1 of 1